tiprankstipranks
Advertisement
Advertisement
Beijing Biostar Sets 2026 AGM to Approve 2025 Results and Seek New Share Issuance Mandate
PremiumCompany AnnouncementsBeijing Biostar Sets 2026 AGM to Approve 2025 Results and Seek New Share Issuance Mandate
3M ago
Beijing Biostar’s Utidelone Data Selected for 2026 ASCO as Trials Show Promising Efficacy and Safety
Premium
Company Announcements
Beijing Biostar’s Utidelone Data Selected for 2026 ASCO as Trials Show Promising Efficacy and Safety
3M ago
Beijing Biostar Tightens Employee Share Option Limit After Clarification
Premium
Company Announcements
Beijing Biostar Tightens Employee Share Option Limit After Clarification
3M ago
Beijing Biostar Reshapes Board to Regain HKEX Compliance After Director Resigns
PremiumCompany AnnouncementsBeijing Biostar Reshapes Board to Regain HKEX Compliance After Director Resigns
4M ago
Beijing Biostar Pharmaceuticals Updates Board and Committee Structure After Director Resignation
Premium
Company Announcements
Beijing Biostar Pharmaceuticals Updates Board and Committee Structure After Director Resignation
4M ago
Beijing Biostar Narrows Loss as Utidelone Oncology Pipeline Advances Globally
Premium
Company Announcements
Beijing Biostar Narrows Loss as Utidelone Oncology Pipeline Advances Globally
5M ago
Beijing Biostar Secures CSRC Filing for H Share Full Circulation Plan
PremiumCompany AnnouncementsBeijing Biostar Secures CSRC Filing for H Share Full Circulation Plan
6M ago
Beijing Biostar Pharmaceuticals Commences Pivotal Clinical Study of Utidelone Injection for HER2-Negative Breast Cancer Brain Metastases
Premium
Company Announcements
Beijing Biostar Pharmaceuticals Commences Pivotal Clinical Study of Utidelone Injection for HER2-Negative Breast Cancer Brain Metastases
8M ago
Beijing Biostar Pharmaceuticals Initiates Receivership for LFM Fund
Premium
Company Announcements
Beijing Biostar Pharmaceuticals Initiates Receivership for LFM Fund
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100